CIK 0001437402
- Large accelerated filer
ARDELYX, INC.
Sign in to watch- Ticker
- ARDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 510-745-7047
- Business address
- 34175 ARDENWOOD BLVD., FREMONT, CA, 94555
- Former names
- NTERYX INC
- 4 Planned sale Blanks Robert sold 38,000 shares at $5.96 ($226,290)
- 4 Grant or award Director acquired 12,204 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 11,023 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 17,322 shares (grant or award)
- 4 Planned sale President & CEO sold 35,000 shares at $6.65 ($232,743)
- 4 Open-market sale Chief Medical Officer sold 145,000 shares at an average $7.12 ($1,033,080)
- 4 Open-market sale Chief Development Officer sold 17,872 shares at $7.00 ($125,104)
- 4 Planned sale President & CEO sold 7,500 shares at $6.72 ($50,390)
- 4 Open-market sale Chief Medical Officer sold 4,794 shares at $7.81 ($37,446)
- 4 Open-market sale Chief Development Officer sold 7,053 shares at $7.81 ($55,091)
- 4 Open-market sale Chief Commercial Officer sold 6,703 shares at $7.81 ($52,357)
- 4 Open-market sale Chief Financial Officer sold 5,167 shares at $7.81 ($40,359)
- 4 Open-market sale President & CEO sold 31,484 shares at $7.81 ($245,922)
- 4 Open-market sale GRAMMER ELIZABETH A sold 6,927 shares at $7.81 ($54,107)
- 4 Open-market sale Felsch Robert Ora sold 3,485 shares at $7.81 ($27,221)
- 4 Open-market sale Blanks Robert sold 4,855 shares at $7.81 ($37,922)
- 4 Planned sale President & CEO sold 3,000 shares at $7.99 ($23,970)
Page 8 of 35 · 690 filings